2023 | 2022 | ||||||
| Underlying | Underlying | ||||||
| business | Non-trading | business | Non-trading | ||||
| performance | items | Total | performance | items | Total | ||
| Note | US$m | US$m | US$m | US$m | US$m | US$m | |
Revenue | 2 | ||||||
Cost of sales | ( | ( | ( | ( | |||
Gross profit | |||||||
Selling and distribution costs | ( | ( | ( | ( | |||
Administration expenses | ( | ( | ( | ( | |||
Other operating income/(expense) | ( | ||||||
Change in fair value of investment properties | 12 | ( | ( | ( | ( | ||
Gain on sale of a subsidiary/asset disposals | 8 | ||||||
Operating (loss)/profit | 3 | ( | ( | ( | ( | ||
Financing charges | ( | ( | ( | ( | |||
Interest income | |||||||
Net financing charges | 4 | ( | ( | ( | ( | ||
| Share of results of associates | |||||||
and joint ventures | 5 | ( | ( | ( | |||
(Loss)/profit before tax | ( | ( | ( | ( | |||
Tax | 6 | ( | ( | ( | ( | ( | |
(Loss)/profit after tax | ( | ( | ( | ( | |||
| Attributable to: | |||||||
Shareholders of the Company | 7&8 | ( | ( | ( | ( | ||
Non-controlling interests | |||||||
( | ( | ( | ( | ||||
US¢ | US¢ | US¢ | US¢ | ||||
(Loss)/earnings per share | 7 | ||||||
– basic | ( | ( | |||||
– diluted | ( | ( |
| 2023 | 2022 | ||
| US$m | US$m | ||
Loss for the year | ( | ( | |
| Other comprehensive expense | |||
| Items that will not be reclassified to profit or loss: | |||
Remeasurements of defined benefit plans | 16 | ( | ( |
Revaluation surplus of right-of-use assets before transfer to investment properties | 11 | ||
Tax on items that will not be reclassified | 6 | ||
( | |||
| Items that may be reclassified subsequently to profit or loss: | |||
| Net exchange translation differences | |||
– net gain/(loss) arising during the year | ( | ||
– transfer to profit and loss | |||
| Cash flow hedges | |||
– net (loss)/gain arising during the year | ( | ||
Tax relating to items that may be reclassified | 6 | ( | |
Share of other comprehensive income of associates and joint ventures | |||
( | |||
Other comprehensive income for the year, net of tax | |||
Total comprehensive expense for the year | ( | ( | |
| Attributable to: | |||
Shareholders of the Company | ( | ( | |
Non-controlling interests | |||
( | ( |
| 2023 | 2022 | ||
| US$m | US$m | ||
| Net assets | |||
Intangible assets | 9 | ||
Tangible assets | 10 | ||
Right-of-use assets | 11 | ||
Investment properties | 12 | ||
Associates and joint ventures | 13 | ||
Other investments | 14 | ||
Deferred tax assets | 15 | ||
Pension assets | 16 | ||
Non-current debtors | 17 | ||
Non-current assets | |||
Stocks | |||
Current debtors | 17 | ||
Current tax assets | |||
Cash and bank balances | 18 | ||
Assets classified as held for sale | 19 | ||
Current assets | |||
Current creditors | 20 | ( | ( |
Current borrowings | 21 | ( | ( |
Current lease liabilities | 22 | ( | ( |
Current tax liabilities | ( | ( | |
( | ( | ||
Liabilities directly associated with assets classified as held for sale | 19 | ( | |
Current liabilities | ( | ( | |
Net current (liabilities)/assets | ( | ||
Long-term borrowings | 21 | ( | ( |
Non-current lease liabilities | 22 | ( | ( |
Deferred tax liabilities | 15 | ( | ( |
Pension liabilities | 16 | ( | |
Non-current creditors | 20 | ( | ( |
Non-current liabilities | ( | ( | |
| Total equity | |||
Share capital | 24 | ||
Share premium | 25 | ||
Revenue and other reserves | |||
Shareholders’ funds | |||
Non-controlling interests | |||
| Asset | Attributable to | Attributable to | Total | |||||||
| Share | Share | Capital | Revenue | revaluation | Hedging | Exchange | shareholders of | non-controlling | equity | |
| capital | premium | reserves | reserves | reserves | reserves | reserves | the Company | interests | ||
| US$m | US$m | US$m | US$m | US$m | US$m | US$m | US$m | US$m | US$m | |
| 2023 | ||||||||||
At 1st January | ( | ( | ||||||||
Total comprehensive income | ( | ( | ( | ( | ||||||
Dividends paid by the Company | ( | ( | ( | |||||||
| Unclaimed dividend | ||||||||||
| forfeited | ||||||||||
| Subsidiary | ||||||||||
| disposed of | ( | – | ( | ( | ||||||
Transfer | ( | |||||||||
At 31st December | ( | ( | ||||||||
| 2022 | ||||||||||
At 1st January | ( | ( | ||||||||
Total comprehensive income | ( | ( | ( | ( | ||||||
Transfer | ( | |||||||||
At 31st December | ( | ( | ||||||||
| Revenue reserves as at 31st December 2023 included cumulative fair value losses on the investment property under |
| development of US$1,207.8 million (2022: US$720.2 million). |
| 2023 | 2022 | ||
| US$m | US$m | ||
| Operating activities | |||
Operating loss | 3 | ( | ( |
Depreciation, amortisation and impairment | |||
Other non-cash items | 28a | ||
Movements in working capital | 28b | ( | ( |
Interest received | |||
Interest and other financing charges paid | ( | ( | |
Tax paid | ( | ( | |
Dividends and interest from associates and joint venture | |||
Cash flows from operating activities | |||
| Investing activities | |||
Purchase of tangible assets | ( | ( | |
Additions to investment properties | ( | ( | |
Purchase of intangible assets | ( | ( | |
Additions to right-of-use assets | ( | ||
Refund on Munich expansion | 28c | ||
Purchase of other investments | ( | ( | |
Purchase of an associate | 28d | ( | |
Advance to associates and joint ventures | 28e | ( | ( |
Repayment of loans to associates and joint ventures | 28f | ||
Sale of a subsidiary | 28g | ||
Net proceeds from asset disposals | 8 | ||
Cash flows from investing activities | |||
| Financing activities | |||
Drawdown of borrowings | 21 | ||
Repayment of borrowings | 21 | ( | ( |
Principal elements of lease payments | 28h | ( | ( |
Dividends paid by the Company | 27 | ( | |
Cash flows from financing activities | ( | ( | |
Net (decrease)/increase in cash and cash equivalents | ( | ||
Cash and cash equivalents at 1st January | |||
Effect of exchange rate changes | ( | ||
Cash and cash equivalents at 31st December | 28i | ||